学生对 University of California San Diego 提供的 Drug Commercialization 的评价和反馈
课程概述
热门审阅
JR
Jan 7, 2017
Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.
PC
Nov 1, 2020
It was a really complete course, I really appreciated the experiences the speakers shared with us and also all the materials were accessible and with a lot of useful information
176 - Drug Commercialization 的 200 个评论(共 255 个)
创建者 NABHAN M H A
•Nov 26, 2021
thanks
创建者 Mintu S T
•Sep 29, 2020
Cool!!
创建者 Atocha C
•Nov 29, 2017
Great!
创建者 林可臻
•Jun 21, 2025
NICE!
创建者 Md. R Q S
•Sep 11, 2020
great
创建者 VULAVALA G
•Feb 22, 2025
good
创建者 Timo Q
•Nov 6, 2024
good
创建者 Sudeepti S M A
•Aug 7, 2024
good
创建者 Farhan s
•Apr 23, 2021
good
创建者 Anaswar U
•Sep 13, 2020
Good
创建者 Uma M K
•Jul 16, 2020
Good
创建者 Mohammad J S
•Sep 25, 2017
good
创建者 名宏 鄭
•Aug 16, 2024
讚
创建者 Julen D L C
•Jan 12, 2020
The course is pretty good and really interesting, but it is too out-of-date. I think that this course would win a lot if actualized. Sometimes, the content should be more accurate, and in order to make it more useful for (future) workers on the pharmaceutical industry, I think this scheme should be followed in all subjects: present a topic --> main keys to follow when working on this area --> practical examples. Thank you!
创建者 Aedrian A
•Jan 16, 2021
This is a highly insightful course on the reality (both the highs and lows) of the drug commercialization process. Unfortunately, as of this writing, the material is relatively outdated. I hope the instructors provide a necessary massive updating of the contents as soon as possible.
创建者 Olivia P L M
•May 22, 2020
Great course that allows me to look somewhat into health economics and other areas such as marketing. It also shows me statistics that can be quite alarming at times. Definitely learnt a lot of interesting terms and built on new knowledge due to this course. Thank you!
创建者 David L
•May 23, 2020
Nice introduction to drug commercialization. It's a bit out of date though. The examples were current at the time, but new modalities, i.e. mAbs, cell and gene therapies, have rapidly overtaken small molecules as the "hottest" entities for commercialization.
创建者 Lucia A
•Mar 24, 2023
I was looking for a course that would give me a general idea of drug commercialization and that could help me fill in the gaps that I had on this subject. I found this course very interesting and useful. The only flaw: it could be more up to date.
创建者 Abram S
•Jun 25, 2020
Holistic view of the commercial side of the industry from many different angles. Excellent and varied speakers with interesting cases. The only negative point is the lack of more current data (ending around 2015).
创建者 Anindita R
•Sep 20, 2020
Liked the course and learned some interesting information about the pharma and biotech industry. I would have appreciated more updated information, however, those can be found on the internet with some research.
创建者 Jamie L F T
•Jun 25, 2020
interesting to learn about how the pharma industry works (as i'm not majoring in any related field) but i think you'd have to take the other 2 courses before this to gain a more complete understanding
创建者 Juan J M C
•Jul 21, 2022
The course on Drug Commercialization really helps you to have a complete vision of the processes that guarantee the availability of safe and effective drugs for worldwide patients all.
创建者 Rutesh A
•Aug 15, 2020
As a student of biotechnology, this course gives us a thorough knowledge of economics of new compound. The market view of the biotechnological development is very much necessary
创建者 Momchil N
•Mar 10, 2020
very good course! Especially weeks 2 and 3 are very interesting and the lecturers were well-organized and structured! I enjoyed it more than the previous two courses
创建者 wungmi m
•Jun 3, 2020
Overall a decent course. Content seems to be outdated as most of them are that of 2013 data. Pharma business model section was really informative and interesting.